Neelufar Mozaffarian - Jul 29, 2024 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
Director
Signature
/s/ Cindy R. Tahl, as Attorney-in-Fact
Stock symbol
FATE
Transactions as of
Jul 29, 2024
Transactions value $
$0
Form type
4
Date filed
7/31/2024, 06:01 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Award $0 +80K $0.00 80K Jul 29, 2024 Common Stock 80K $5.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest in 36 equal monthly installments after the grant date, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date.